Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive study aims to boost care in Semi-Intensive units

NCT ID NCT04676347

Knowledge-focused Sponsor: Mario Negri Institute for Pharmacological Research Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to create a system for continuously evaluating healthcare quality in semi-intensive care units. Researchers will track outcomes like transfers to intensive care or death in the hospital for 39,000 patients. The goal is to identify areas for improvement and enhance patient care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better care standards and reduced complications for patients in semi-intensive care units.
What could go wrong
This is an observational study, so it won't test a new treatment. Results may not directly improve care without further action.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 39,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2021

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

all patients hospitalised in a semi-intensive care unit attending the study, during a 5 years period of time (from 1st january 2021, to 31st december 2025)

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * all patients hospitalised in a semi-intensive care unit Exclusion Criteria: * None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Evaluation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Evaluation Quality Semi-intensive care unit

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AOU Padova

    RECRUITING

    Padova, Italy

  • AOU Policlinico S. Marco

    RECRUITING

    Catania, Italy

  • AOU San Luigi Gonzaga

    RECRUITING

    Orbassano, 10043, Italy

  • AOU di Sassari

    RECRUITING

    Sassari, Italy

  • ASO SS Antonio e Biagio e Cesare Arrigo

    RECRUITING

    Alessandria, 15121, Italy

  • ASST Lodi

    NOT_YET_RECRUITING

    Lodi, Italy

  • Istituto di Ricerche Farmacologiche Mario Negri IRCCS

    ACTIVE_NOT_RECRUITING

    Milan, Milan, 20156, Italy

  • Ospedale Bufalini

    RECRUITING

    Cesena, Italy

  • Ospedale Ca' Foncello

    ACTIVE_NOT_RECRUITING

    Treviso, Italy

  • Ospedale E.Agnelli

    RECRUITING

    Pinerolo, 10064, Italy

  • Ospedale Giovanni Bosco

    RECRUITING

    Torino, Italy

  • Ospedale Maggiore

    RECRUITING

    Bologna, Italy

  • Ospedale Michele e Pietro Ferrero

    RECRUITING

    Verduno, Italy

  • Ospedale San Bassiano

    RECRUITING

    Bassano del Grappa, Italy

  • Ospedale Sant'Eugenio

    RECRUITING

    Roma, 00144, Italy

  • Ospedale Santa Maria delle Grazie

    RECRUITING

    Naples, Italy

  • Ospedale degli Infermi

    RECRUITING

    Rivoli, Italy

  • Ospedali Riuniti

    NOT_YET_RECRUITING

    Livorno, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.